Duvvuru Varshitha Reddy and Vimal Kumar developed Vivalyf Innovations around Easy Life, a proposed health-monitoring device intended to reduce reliance on finger-prick testing. The startup positioned the product as a medical-technology research and development effort.

The founders appeared on Shark Tank India Season 1 asking for ₹56 lakh for 7.5% equity. Peyush Bansal and Anupam Mittal agreed to invest ₹56 lakh for 33.33%, giving the company the requested capital at a substantially lower valuation.

Any device intended to measure glucose or guide diabetes decisions requires appropriate validation and regulatory oversight. The television pitch and company descriptions do not substitute for independent clinical evidence, and this article does not present Easy Life as an approved replacement for conventional testing.

Vivalyf Innovations Private Limited was incorporated in Telangana in 2021. Registry-derived information lists the company as active and unlisted. Its public profile references financial information beginning in FY2022, but a reliable recent revenue value is not available in the accessible record.

The absence of current audited revenue and product approval details limits the claims that can be made about commercial scale. An active legal company does not necessarily mean that a medical device has entered large-scale clinical or retail use.

The defensible current position is therefore narrower than the original ambition. Vivalyf secured a ₹56 lakh televised investment and its incorporated entity remains active as of August 25, 2026. Public information reviewed for this report does not establish current sales, profitability, regulatory approval or widespread deployment, so those outcomes remain unverified.

The distinction is especially important for health technology. A prototype can demonstrate an engineering approach without meeting the accuracy, repeatability, clinical-validation and regulatory requirements required for routine patient decisions. Until Vivalyf publishes product-specific approvals or validated performance data, the company’s active legal status should not be interpreted as confirmation that Easy Life is commercially approved for diabetes management.

Sources: Vivalyf Innovations company profile; Shark Tank India Season 1 pitch table.